Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AgfiledCriticalBayer Healthcare Ag
Priority to UY26502ApriorityCriticalpatent/UY26502A1/en
Publication of UY26502A1publicationCriticalpatent/UY26502A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere al campo de la coagulación sanguínea. Se describen nuevos derivados de oxazolidinona de fórmula general (I) procedimiento para su preparación así como principio activo en medicamentos para la profilaxis y/o tratamiento de enfermedades.The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of general formula (I) are described, a process for their preparation as well as an active ingredient in medicines for the prophylaxis and / or treatment of diseases.
UY26502A2000-12-222000-12-22
SUBSTITUTED OXAZOLIDINONES AND THEIR USE
UY26502A1
(en)
BENZIMIDAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLIA AS INFLAMMATORY, ALLERGIC, INFECTIOUS OR AUTOIMUNE DISEASES